1. Home
  2. RCON vs SCLX Comparison

RCON vs SCLX Comparison

Compare RCON & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Recon Technology Ltd.

RCON

Recon Technology Ltd.

N/A

Current Price

$0.90

Market Cap

25.4M

Sector

Energy

ML Signal

N/A

Logo Scilex Holding Company

SCLX

Scilex Holding Company

BUY

Current Price

$2.33

Market Cap

27.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
RCON
SCLX
Founded
2007
2011
Country
China
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.4M
27.9M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
RCON
SCLX
Price
$0.90
$2.33
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 113.0K
41.0K
Earning Date
09-30-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$6,430,788.00
★ $30,253,000.00
Revenue This Year
N/A
$118.16
Revenue Next Year
$10.08
$186.31
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.02
$2.45
52 Week High
$6.42
$27.00

Technical Indicators

Market Signals
Indicator
RCON
SCLX
Relative Strength Index (RSI) 38.53 16.71
Support Level $0.79 N/A
Resistance Level $1.04 $7.77
Average True Range (ATR) 0.11 0.25
MACD -0.01 -0.01
Stochastic Oscillator 13.29 5.06

Price Performance

Historical Comparison
RCON
SCLX

About RCON Recon Technology Ltd.

Recon Technology Ltd provides automation systems, industrial equipment, and support services tailored for the oil and gas industry in China. The company's business spans key segments such as automation products and software, equipment and accessories, oilfield environmental protection, and platform outsourcing services. It generates the majority of its revenue by providing integrated automation services to Chinese petroleum companies at oilfields. Its key products and services include pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system. The company's operations are centered on servicing upstream clients throughout China, with some broader industrial automation solutions.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: